ArticleJournal of cellular and molecular medicine2019

DYRK1A inhibition suppresses STAT3/EGFR/Met signalling and sensitizes EGFR wild-type NSCLC cells to AZD9291.

Yang-Ling Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.